Pages that link to "Q33345226"
Jump to navigation
Jump to search
The following pages link to Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome (Q33345226):
Displaying 50 items.
- Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome (Q24543850) (← links)
- Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications (Q24681724) (← links)
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome (Q24685473) (← links)
- Genetic variants in the complement system predisposing to age-related macular degeneration: a review (Q27021836) (← links)
- Properdin: a tightly regulated critical inflammatory modulator (Q28069187) (← links)
- Production of biologically active recombinant human factor H in Physcomitrella (Q28290970) (← links)
- Production of biologically active complement factor H in therapeutically useful quantities (Q28300280) (← links)
- The development of atypical hemolytic uremic syndrome depends on complement C5 (Q28300378) (← links)
- Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure (Q28301693) (← links)
- The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. (Q30377280) (← links)
- Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome (Q33347509) (← links)
- Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries (Q33349831) (← links)
- Genetic screening in haemolytic uraemic syndrome (Q33357183) (← links)
- Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome (Q33357218) (← links)
- Challenges in the management of infantile factor H associated hemolytic uremic syndrome. (Q33361337) (← links)
- Atypical haemolytic uraemic syndrome and mutations in complement regulator genes (Q33368691) (← links)
- An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations (Q33369200) (← links)
- Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. (Q33370511) (← links)
- A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders (Q33371578) (← links)
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome (Q33373674) (← links)
- Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development (Q33374478) (← links)
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains (Q33375335) (← links)
- Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen (Q33377284) (← links)
- Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. (Q33377799) (← links)
- Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. (Q33378236) (← links)
- The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome (Q33378469) (← links)
- Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation (Q33379624) (← links)
- What's new in haemolytic uraemic syndrome? (Q33380073) (← links)
- Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population (Q33382404) (← links)
- Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome (Q33384039) (← links)
- DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome (Q33388274) (← links)
- Atypical hemolytic uremic syndrome in the Tunisian population. (Q33389773) (← links)
- Genetics and complement in atypical HUS. (Q33389945) (← links)
- Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome (Q33391370) (← links)
- The role of endothelial cell injury in thrombotic microangiopathy (Q33391882) (← links)
- Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities (Q33393852) (← links)
- Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance (Q33396948) (← links)
- Age-related penetrance of hereditary atypical hemolytic uremic syndrome (Q33397115) (← links)
- Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations (Q33398546) (← links)
- Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. (Q33398635) (← links)
- Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein (Q33400705) (← links)
- Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions (Q33405609) (← links)
- The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome. (Q33422057) (← links)
- Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. (Q33425911) (← links)
- Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders (Q33437488) (← links)
- Complement factor H is expressed in adipose tissue in association with insulin resistance (Q33556525) (← links)
- Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration (Q34155381) (← links)
- Complement System Part I - Molecular Mechanisms of Activation and Regulation (Q34481071) (← links)
- Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families (Q35026701) (← links)
- Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration (Q35178889) (← links)